[
  {
    "content": "\nMIMIC-IV Database Overview\n\nMIMIC-IV (Medical Information Mart for Intensive Care IV) is a large, freely available \ndatabase of de-identified intensive care unit (ICU) admissions. The database is developed, \nmaintained, and hosted by the MIT Laboratory for Computational Physiology.\n\nDatabase Statistics:\n- Contains data from ~380,000 unique admissions to ICUs\n- Covers intensive care unit stays between 2008 and 2019\n- Includes ~345,000 unique patients\n- 100+ variables per admission including vital signs, medications, lab tests, and procedures\n\nKey Data Elements:\n1. Patient Demographics: age, gender, ethnicity, marital status\n2. Admission Data: admission type, source, insurance, language\n3. Clinical Data: vital signs, lab values, medications, procedures\n4. Outcome Data: mortality, length of stay, discharge disposition\n\nData Quality:\n- De-identified using HIPAA-compliant standards\n- Covers a diverse ICU population\n- Includes both medical and surgical admissions\n- Comprehensive temporal data for longitudinal analysis\n\nClinical Applications:\n- ICU risk prediction models\n- Clinical decision support systems\n- Benchmarking hospital performance\n- Epidemiological research\n- Drug safety and adverse event detection\n",
    "metadata": {
      "source": "MIMIC-IV_Overview",
      "type": "reference_documentation",
      "record_type": "database_reference"
    }
  },
  {
    "content": "\nCommon ICU Diagnoses in MIMIC-IV Database\n\nBased on analysis of MIMIC-IV admissions, the following are among the most common diagnoses:\n\nCardiovascular Conditions:\n- Hypertension (HTN): Blood pressure disorder affecting 40-50% of ICU admissions\n- Coronary artery disease (CAD): Leading cause of ICU admission\n- Acute myocardial infarction (MI): Heart attack requiring intensive monitoring\n- Atrial fibrillation (AFib): Common arrhythmia in critically ill patients\n- Heart failure: Reduced ejection fraction requiring intensive support\n\nRespiratory Conditions:\n- Pneumonia: Bacterial or viral infection of lungs\n- COPD (Chronic obstructive pulmonary disease): Chronic lung disease\n- Acute respiratory distress syndrome (ARDS): Severe lung inflammation\n- Asthma exacerbation: Acute worsening of asthma\n\nMetabolic and Renal:\n- Acute kidney injury (AKI): Sudden loss of kidney function\n- Chronic kidney disease (CKD): Long-term kidney dysfunction\n- Diabetes mellitus: Blood sugar regulation disorder\n- Sepsis: Life-threatening infection response\n\nNeurological:\n- Stroke: Cerebrovascular accident\n- Seizures: Abnormal electrical brain activity\n- Traumatic brain injury (TBI): Head trauma with brain damage\n- Encephalopathy: Brain dysfunction from various causes\n\nGI and Hepatic:\n- Acute liver failure: Rapid loss of liver function\n- Gastrointestinal bleeding: Bleeding in digestive tract\n- Pancreatitis: Inflammation of pancreas\n- Peritonitis: Inflammation of abdominal membrane\n",
    "metadata": {
      "source": "MIMIC-IV_Common_Diagnoses",
      "type": "reference_documentation",
      "record_type": "clinical_reference"
    }
  },
  {
    "content": "\nCommon Medications in MIMIC-IV Database\n\nMIMIC-IV contains detailed medication administration records including dosages, routes,\nand timing. Common medication classes in ICU admissions include:\n\nCardiovascular Medications:\n- Beta-blockers (metoprolol, esmolol): Heart rate and blood pressure control\n- ACE inhibitors: Blood pressure and heart failure management\n- Vasopressors (dopamine, norepinephrine): Blood pressure support\n- Anticoagulants (heparin, warfarin): Clot prevention\n- Antiplatelet agents (aspirin, clopidogrel): Thrombotic event prevention\n\nAntibiotics:\n- Beta-lactams (penicillins, cephalosporins): Bacterial infection treatment\n- Fluoroquinolones: Broad-spectrum infection coverage\n- Aminoglycosides: Gram-negative coverage\n- Vancomycin: Methicillin-resistant Staphylococcus aureus (MRSA) coverage\n- Antifungals: Fungal infection treatment\n\nSedation and Pain Control:\n- Propofol: Anesthetic agent for sedation\n- Midazolam: Benzodiazepine for sedation\n- Fentanyl: Opioid analgesic for pain control\n- Morphine: Opioid for pain and dyspnea relief\n- Dexmedetomidine: Alpha-2 agonist for sedation\n\nRespiratory Support:\n- Albuterol: Bronchodilator for airway management\n- Ipratropium: Anticholinergic bronchodilator\n- Methylxanthines (theophylline): Bronchodilation\n- Inhaled nitric oxide: Pulmonary vasodilator\n\nMetabolic:\n- Insulin: Blood glucose control\n- Corticosteroids (dexamethasone, hydrocortisone): Inflammation reduction\n- Diuretics (furosemide, spironolactone): Fluid management\n",
    "metadata": {
      "source": "MIMIC-IV_Medications",
      "type": "reference_documentation",
      "record_type": "medication_reference"
    }
  },
  {
    "content": "\nVital Signs and Lab Values in MIMIC-IV\n\nMIMIC-IV contains high-frequency vital signs and laboratory values for ICU patients.\nThese are critical for monitoring patient condition and guiding clinical decisions.\n\nVital Signs:\n- Heart Rate (HR): 40-200 bpm; normal range 60-100 bpm at rest\n- Blood Pressure (BP): Systolic and diastolic; normal <120/80 mmHg\n  - Systolic (SBP): Normal <120, elevated 120-129, high \u2265130\n  - Diastolic (DBP): Normal <80, elevated \u226580\n- Respiratory Rate (RR): 12-20 breaths/minute normal range\n- Temperature: Normal 36.5-37.5\u00b0C (97.7-99.5\u00b0F)\n- Oxygen Saturation (SpO2): Normal \u226595% on room air\n\nHemodynamic Monitoring:\n- Central Venous Pressure (CVP): 2-8 mmHg normal\n- Pulmonary Artery Pressure (PAP): 15-30 systolic, 5-15 diastolic\n- Cardiac Output (CO): 4-8 L/min normal range\n- Mixed Venous Oxygen Saturation (SvO2): \u226570% indicates adequate perfusion\n\nLaboratory Values (Common):\n- Complete Blood Count (CBC):\n  - Hemoglobin (Hgb): 13.5-17.5 g/dL (male), 12.0-15.5 g/dL (female)\n  - Hematocrit (Hct): 40-54% (male), 36-46% (female)\n  - White Blood Cell (WBC): 4.5-11.0 \u00d7 10^9/L\n  - Platelet Count: 150-400 \u00d7 10^9/L\n\n- Comprehensive Metabolic Panel (CMP):\n  - Sodium (Na+): 135-145 mEq/L\n  - Potassium (K+): 3.5-5.0 mEq/L\n  - Chloride (Cl-): 98-107 mEq/L\n  - Carbon Dioxide (CO2): 23-29 mEq/L\n  - Blood Urea Nitrogen (BUN): 7-20 mg/dL\n  - Creatinine: 0.7-1.3 mg/dL\n  - Glucose: 70-100 mg/dL fasting\n\n- Liver Function Tests:\n  - Aspartate Aminotransferase (AST): 10-40 IU/L\n  - Alanine Aminotransferase (ALT): 7-56 IU/L\n  - Total Bilirubin: 0.1-1.2 mg/dL\n  - Albumin: 3.5-5.5 g/dL\n\n- Coagulation:\n  - Prothrombin Time (PT): 11-13.5 seconds\n  - Partial Thromboplastin Time (PTT): 25-35 seconds\n  - International Normalized Ratio (INR): 0.8-1.1\n\n- Arterial Blood Gas (ABG):\n  - pH: 7.35-7.45\n  - Partial Pressure of Carbon Dioxide (PaCO2): 35-45 mmHg\n  - Partial Pressure of Oxygen (PaO2): 80-100 mmHg\n  - Bicarbonate (HCO3-): 22-26 mEq/L\n  - Oxygen Saturation (SaO2): 95-100%\n",
    "metadata": {
      "source": "MIMIC-IV_Vital_Signs",
      "type": "reference_documentation",
      "record_type": "vital_signs_reference"
    }
  }
]